GCM
Glenview Capital Management Portfolio holdings
AUM
$3.52B
This Quarter Return
-4.14%
1 Year Return
+13.71%
3 Year Return
+64.03%
5 Year Return
+172.03%
10 Year Return
+274.64%
AUM
$5.48B
AUM Growth
+$5.48B
(-9.3%)
Cap. Flow
-$266M
Cap. Flow
% of AUM
-4.85%
Top 10 Holdings %
Top 10 Hldgs %
50.11%
Holding
71
New
6
Increased
15
Reduced
35
Closed
11
Top Buys
| 1 |
Willis Towers Watson
WTW
|
$194M |
| 2 |
Uber
UBER
|
$88.3M |
| 3 |
Baxter International
BAX
|
$80.3M |
| 4 |
Global Payments
GPN
|
$64.5M |
| 5 |
McKesson
MCK
|
$49.6M |
Top Sells
| 1 |
Tenet Healthcare
THC
|
$132M |
| 2 |
WBA
Walgreens Boots Alliance
WBA
|
$121M |
| 3 |
Amazon
AMZN
|
$71M |
| 4 |
PARA
Paramount Global Class B
PARA
|
$67.2M |
| 5 |
DXC Technology
DXC
|
$54.2M |
Sector Composition
| 1 | Healthcare | 60.28% |
| 2 | Technology | 10.12% |
| 3 | Industrials | 7.36% |
| 4 | Materials | 5.97% |
| 5 | Communication Services | 5.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Tenet Healthcare
THC
$16.3B
| $575M | 10.43% | 8,652,741 -1,992,579 | -19% | -$132M |
|
2
Bausch Health
BHC
$2.74B
| $436M | 7.9% | 15,649,243 -688,306 | -4% | -$19.2M |
|
|
3
McKesson
MCK
$85.4B
| $345M | 6.26% | 1,731,042 +248,972 | +17% | +$49.6M |
|
4
Cigna
CI
$80.3B
| $265M | 4.8% | 1,322,827 +38,474 | +3% | +$7.7M |
|
5
Cencora
COR
$56.5B
| $225M | 4.09% | 1,886,005 +166,689 | +10% | +$19.9M |
|
|
6
Global Payments
GPN
$21.5B
| $211M | 3.82% | 1,336,257 +409,291 | +44% | +$64.5M |
|
|
7
Willis Towers Watson
WTW
$31.9B
| $194M | 3.51% | +832,798 | New | +$194M |
|
|
8
DXC Technology
DXC
$2.59B
| $188M | 3.41% | 5,601,965 -1,611,364 | -22% | -$54.2M |
|
|
9
Baxter International
BAX
$12.7B
| $174M | 3.16% | 2,167,722 +998,335 | +85% | +$80.3M |
|
10
Alphabet (Google) Class A
GOOGL
$2.57T
| $134M | 2.44% | 50,262 -5,482 | -10% | -$14.7M |
|
11
Takeda Pharmaceutical
TAK
$47.3B
| $133M | 2.41% | 8,102,119 -1,013,402 | -11% | -$16.6M |
|
12
Centene
CNC
$14.3B
| $132M | 2.4% | 2,122,427 +101,460 | +5% | +$6.32M |
|
13
HCA Healthcare
HCA
$94.5B
| $127M | 2.31% | 525,237 -141,698 | -21% | -$34.4M |
|
14
Aptiv
APTV
$17.3B
| $123M | 2.22% | 823,467 +302,954 | +58% | +$45.1M |
|
15
Universal Health Services
UHS
$11.6B
| $122M | 2.21% | 879,079 -130,377 | -13% | -$18M |
|
16
Coca-Cola Europacific Partners
CCEP
$40.4B
| $121M | 2.2% | 2,194,816 -91,017 | -4% | -$5.03M |
|
|
17
Uber
UBER
$196B
| $109M | 1.98% | 2,432,683 +1,972,091 | +428% | +$88.3M |
|
|
PARA
18
DELISTED
Paramount Global Class B
PARA
| $105M | 1.91% | 2,667,822 -1,700,855 | -39% | -$67.2M |
|
19
DuPont de Nemours
DD
$32.2B
| $104M | 1.88% | 1,522,425 +278,744 | +22% | +$19M |
|
20
Corteva
CTVA
$50.4B
| $93.6M | 1.7% | 2,224,846 -5,622 | -0.3% | -$237K |
|
21
Molina Healthcare
MOH
$9.8B
| $89.6M | 1.62% | 330,105 +32,686 | +11% | +$8.87M |
|
22
Boston Scientific
BSX
$156B
| $89.5M | 1.62% | 2,063,297 -259,719 | -11% | -$11.3M |
|
23
Brookdale Senior Living
BKD
$1.83B
| $84.8M | 1.54% | 13,454,840 -1,252,416 | -9% | -$7.89M |
|
24
Myriad Genetics
MYGN
$593M
| $72.2M | 1.31% | 2,235,168 -240,912 | -10% | -$7.78M |
|
25
FMC
FMC
$4.88B
| $70.7M | 1.28% | 772,099 -100,458 | -12% | -$9.2M |
|